News | November 03, 2021
Sun Pharma Q2FY22 PAT jumps to Rs 2088.73 Cr
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The company is a medical dictation solution used by medical practitioners
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
